tiprankstipranks

James Clemmer Insider Profile

4 Followers
James Clemmer, President & CEO, Director at AngioDynamics, holds 862.45K shares in AngioDynamics (Ticker: ANGO), holds 62.08K shares in Lantheus (Ticker: LNTH), holds 0.00 shares in Covidien (Ticker: COV).
tipranks
James Clemmer

James Clemmer
AngioDynamics (ANGO)
President & CEO, Director

Ranked #6,542 out of 108,328 Corporate Insiders

Profitable Transactions

63%
5 out of 8 Profitable Transactions

Average Return

+38.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$19M
67.34%
32.66%
A breakdown of James Clemmer's holdings

Insider Roles

AngioDynamics
(ANGO)
President & CEO, Director
Lantheus
(LNTH)
Director
Roles that James Clemmer holds in companies

Most Profitable Insider Trade

Stock:
AngioDynamics
(ANGO)
Rating:Informative Buy
Date:Aug 03, 2020 - Aug 03, 2021
Return:+225.90%
The most profitable trade made by James Clemmer

James Clemmer's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
AngioDynamics
Jul 24, 2026
President & CEO, Director
Uninformative Buy
354.21K
$12.76M
COV
Covidien
Jan 28, 2015
Uninformative Sell
Lantheus
Mar 05, 2020
Director
Uninformative Buy
$6.19M
List of latest transactions for each holding click on a transaction to see James Clemmer's performance on stock

James Clemmer insider profile FAQ

What is the percentage of profitable transactions made by James Clemmer?
The percentage of profitable transactions made by James Clemmer is 63%.
    What is the average return per transaction made by James Clemmer?
    The average return per transaction made by James Clemmer is 38.30%.
      What stocks does James Clemmer hold?
      James Clemmer holds: ANGO, COV, LNTH stocks.
        What was James Clemmer’s latest transaction?
        James Clemmer latest transaction was an Uninformative Buy of $354.21K.
          What was James Clemmer's most profitable transaction?
          James Clemmer’s most profitable transaction was an Informative Buy of ANGO stock on August 3, 2020. The return on the trade was 225.90%.
            What is James Clemmer's role in AngioDynamics?
            James Clemmer's role in AngioDynamics is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.